This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages) This article contains promotional content . Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view.(June 2025) ( Learn how and when to remove this message ) This article may rely excessively on sources too closely associated with the subject , potentially preventing the article from being verifiable and neutral. Please help improve it by replacing them with more appropriate citations to reliable, independent sources.(June 2025) ( Learn how and when to remove this message ) ( Learn how and when to remove this message )

Meru Health is an American company that delivers smartphone-based programmes for depression, anxiety and related conditions. It was founded in Helsinki in 2016 and relocated its headquarters to California after taking part in Y Combinator's Summer 2018 cohort. ^[1]

Contents

• History
• Funding
• Products
• Clinical outcomes
• Peer-reviewed studies
• Partnerships and pilots
• Media coverage
• See also
• References
• External links

History

Entrepreneurs Kristian Ranta, Albert Nazander and Riku Lindholm launched Meru Health after the suicide of Kristian's brother, aiming to widen access to evidence-based mental-health care. ^[2]

Funding

Tracxn estimates total disclosed funding at about US$55 million. ^[5]

Products

• Meru Health Program – a 12-week intervention that combines cognitive-behavioural therapy, mindfulness practice, nutritional guidance and heart-rate-variability biofeedback, supported by licensed therapists via asynchronous chat.
• A shorter coaching programme for stress and burnout.

Clinical outcomes

• A 12-week randomised trial (n = 100) reported a mean 6.4-point drop in PHQ-9 scores and a 5.1-point drop in GAD-7 relative to a wait-list control. ^[6]
• A 2019 follow-up study (n = 193) found that mean PHQ-9 reductions of 6.67 points were maintained at 12 months. ^[7]
• The Peterson Health Technology Institute's 2025 assessment classified the programme as clinically meaningful, citing improvements in both PHQ-9 and GAD-7. ^[8]

Partnerships and pilots

• Stanford University – the 12-week programme is offered at no cost to benefits-eligible employees through university health plans. ^[11]
• Curebase – collaboration to run a 300-participant clinical trial embedded in primary-care clinics. ^[12]
• MINES & Associates – partnership announced in 2019 to make the programme available to more than 10,000 managed-behavioural-health members. ^[13]

Media coverage

National outlets, including TechCrunch, Forbes, Fierce Healthcare and MobiHealthNews, have reported on the company's funding rounds, clinical results and commercial agreements. ^{[2] [4] [14]}

See also

• Digital therapeutics
• Telehealth
• Mental health in the United States

References

External links

• Official website